Primary anastomosis vs nonrestorative resection for perforated diverticulitis with peritonitis: A prematurely terminated randomized controlled trial

Colorectal Disease

Volumn 14, Issue 11, 2012, Pages 1403-1410

  Binda, G A ^a   Karas, J R ^b   Serventi, A ^a   Sokmen, S ^c   Amato, A ^d   Hydo, L ^b   Bergamaschi, R ^b,e  

^a GALLIERA HOSPITAL   (Italy)

^b STONY BROOK UNIVERSITY   (United States)

^c DOKUZ EYLUL UNIVERSITY   (Turkey)

^d Sanremo Hospital   (Italy)

^e UNIVERSITY OF BERGEN   (Norway)

Author keywords

Nonrestorative resection; Perforated diverticulitis; Peritonitis; Primary anastomosis; Randomized controlled trial

Indexed keywords

ANTIBIOTIC AGENT; INOTROPIC AGENT;

ABDOMINAL ABSCESS; ADULT; AGED; ANASTOMOSIS LEAKAGE; ANTIBIOTIC PROPHYLAXIS; APACHE; ARTICLE; COLON ANASTOMOSIS; COLON RESECTION; COLOSTOMY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DIVERTICULITIS; FEMALE; HEART DISEASE; HINCHEY STAGE; HUMAN; ILEOSTOMY; INFECTION; KIDNEY DYSFUNCTION; LAPAROSCOPIC SURGERY; LOOP ILEOSTOMY; LUNG DISEASE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MANNHEIM PERITONITIS INDEX; MORBIDITY; MULTICENTER STUDY; OPERATION DURATION; PERFORATED DIVERTICULITIS; PERITONEUM LAVAGE; PERITONITIS; PNEUMONIA; PRIMARY ANASTOMOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SEX DIFFERENCE; STOMA; SURGICAL APPROACH; SURGICAL DRAINAGE; SURGICAL INFECTION; SURGICAL MORTALITY; SURGICAL PATIENT; SURGICAL RISK; SURGICAL TECHNIQUE; URINARY TRACT INFECTION; URINE CULTURE;

ANALYSIS OF VARIANCE; ANASTOMOSIS, SURGICAL; COLECTOMY; COLON; COLOSTOMY; DIVERTICULITIS, COLONIC; FEMALE; HUMANS; ILEOSTOMY; INTESTINAL PERFORATION; MALE; MIDDLE AGED; PERITONITIS; POSTOPERATIVE COMPLICATIONS; SURGICAL STOMAS; TREATMENT OUTCOME;

EID: 84867390630     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2012.03117.x     Document Type: Article

References (27)

1. Constantinides VA, Tekkis PP, Senapati A; Association of Coloproctology of Great Britain Ireland. Prospective multicentre evaluation of adverse outcomes following treatment for complicated diverticular disease. Br J Surg 2006;93:1503-13.
2. Masoomi H, Buchberg BS, Magno C, Mills SD, Stamos MJ. Trends in diverticulitis management in the United States from 2002 to 2007. Arch Surg 2011; 146: 400-6.
3. Schwesinger WH, Page CP, Gaskill HV III et al. Operative management of diverticular emergencies: strategies and outcomes. Arch Surg 2000; 135: 558-62.
4. Zorcolo L, Covotta L, Carlomagno N, Bartolo DC. Safety of primary anastomosis in emergency colo-rectal surgery. Colorectal Dis 2003; 5: 262-9.
5. Touzios JG, Dozois EJ. Diverticulosis and acute diverticulitis. Gastroenterol Clin North Am 2009; 38: 513-25.
6. Rafferty J, Shellito P, Hyman NH, Buie WD; Standards Committee of American Society of Colon and Rectal Surgeons. Practice parameters for sigmoid diverticulitis. Dis Colon Rectum 2006;49:939-44.
7. Awad SS, Gale SC. (2007) Multiple organ dysfunction syndrome: pathogenesis, management, and prevention. In: Mastery of Surgery, 5th edn (eds Fischer JE, Bland KI, et al. ), pp. 110-25. Lippincott Williams & Wilkins: Philadelphia.
8. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309-32.
9. Begg C, Cho M, Eastwood S et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996; 276: 637-9.
10. Knaus WA, Wagner DP, Draper EA et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100: 1619-36.
11. Hinchey EJ, Schaal PG, Richard GK. Treatment of diverticular disease of the colon. Adv Surg 1978; 12: 85-109.
12. Linder MM, Wacha H, Feldmann U, Wesch G, Streifensand RA, Gundlach E. Der Mannheimer Peritonitis-Index. Chirurg 1987; 58: 84-92.
13. World Medical Association (WMA). Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. http://www.wma.net/en/30publications/10policies/b3/index.html> (accessed August 2011).
14. Champion HR, Fingerhut A, Escobar MA, Weiskopf RB. The role of data and safety monitoring in acute trauma resuscitation research. J Am Coll Surg 2007; 204: 73-83.
15. Zeitoun G, Laurent A, Rouffet F et al. Multicentre, randomized clinical trial of primary vs secondary sigmoid resection in generalized peritonitis complicating sigmoid diverticulitis. Br J Surg 2000; 87: 1366-74.
16. Kronborg O. Treatment of perforated sigmoid diverticulitis: a prospective randomized trial. Br J Surg 1993; 80: 505-7.
17. Glasziou P, Chalmers I, Rawlins M, McCulloch P. When are randomised trials unnecessary? Picking signal from noise BMJ 2007; 334: 349-51.
18. Van der Linden W. Pitfalls in randomized surgical trials. Surgery 1980; 87: 258-62.
19. Doran FSA. (1964) An assessment of the relative merit of different techniques. In: Hernia (eds Nyhus LM, Harkins HN), pp. 160. JB Lippincott: Philadelphia.
20. Johnson AG, Dixon JM. Removing bias in surgical trials. BMJ 1997; 314: 916-7.
21. van der Broek MA, van Dam RM, Malagó M, Dejong CH, van Breukelen GJ, Olde Damink SW. Feasibility of randomized controlled trials in liver surgery using surgery-related mortality or morbidity as endpoint. Br J Surg 2009; 96: 1005-14.
22. van der Broek MA, van Dam RM, van Breukelen GJ et al. Development of a composite endpoint for randomized controlled trials in liver surgery. Br J Surg 2011; 98: 1138-45.
23. Kernan WN, Viscoli CM, Makuch RW et al. Stratified randomization for clinical trials. J Clin Epidemiol 1999; 52: 19-26.
24. Devereaux PJ, Bhandari M, Clarke M et al. Need for expertise based randomized controlled trials. BMJ 2005; 330: 88.
25. Korn EL, Freidlin B. Inefficacy interim monitoring procedures in randomized controlled trials: the need to report. Am J Bioeth 2011; 11: 2-10.
26. Pocock SJ. When (not) to stop a clinical trial for benefit. JAMA 2005; 295: 2228-30.
27. Lievre M, Menard J, Bruckert E et al. Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility. BMJ 2001; 322: 603-5.